The Global Endometrial Ablation Systems Market Size is valued at 3.15 Billion in 2022 and is predicted to reach 5.42 Billion by the year 2031 at a 6.5 % CAGR during the forecast period for 2023-2031.
The device that is used by gynecologist to perform endometrial ablation on an outpatient basis are known as endometrial ablation systems. Endometrial ablation is a procedure that is used for the treatment of abnormal uterine bleeding (menorrhagia). The Hydro ThermAblator System destroys all or most of the tissue that is responsible for abnormal menstrual bleeding (the endometrium). It is potential alternative to hysterectomy and for other major surgical procedure. The procedure is generally safe, minimize recovery time, and have minimal side effects. The Hydro ThermAblator System utilizes procedure sheath which is placed in cervix after slight dilation of cervix by hot saline. The system allows saline heated to 90 degree Celsius which is to be circulated through uterus. As the heated saline comes in contact with the uterine walls, the saline will begin to heat the endometrium. This heat is intended to destroy the affected tissue of endometrium.
Market Segmentation
The global endometrial ablation Systems market is segmented based on techniques, end user and geography. Based on the Technology, the market is segmented into Cryoablation, Radiofrequency Ablation, Hydrothermal Ablation, Hysteroscopic Ablation, Thermal Balloon, and Others. On the basis of end user the market is segmented into Hospitals, ambulatory surgical centers and others. Hospital segment is expected to hold maximum share of the market due to increase in number of hospital visits and hospital stay. Increase in incidence and prevalence of gynecological disease expected to fuel the growth of the global Endometrial Ablation Systems Market in forecast period. Furthermore, technological advancement, and growing awareness about ablation technique further contribute to the growth of the market. However, stringent regulatory environment and risk associated with hydro termablator system impede the growth of the global Endometrial Ablation Systems Market.
Based on geography, the global endometrial ablation systems market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In terms of revenue, North America followed by Europe is major contributor for the global endometrial ablation systems market. This is because rise in incidence and prevalence of menorrhagia and other gynecological related diseases, presence of developed healthcare infrastructure, increasing research and drug development activities, presence of major players, and growing number of merger and acqusition, propels the growth of the market in the region. Asia Pacific is third promising revenue contributor which is expected to grow at rapid pace in upcoming year. Countries such as Japan, India and China are major contributors for this market. Emerging and huge population base countries such as China and India offer tremendous market opportunities for the global Endometrial Ablation Systems Market.
Competitive Landscape
Some Of The key players in the Global Endometrial Ablation Systems Market:
- Smith & Nephew Plc,
- Olympus Corporation,
- Boston Scientific Corporation,
- Karl Storz GmbH & Co. KG,
- Ethicon, LLC. (Johnson & Johnson),
- Medtronic Plc,
- Hologic Corporation,
- Minerva Surgical, Inc.,
- The Cooper Companies, Inc. (Cooper Surgical Inc.),
- AngioDynamics Inc.
The Endometrial Ablation Systems Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 3.15 Billion |
|
Revenue Forecast In 2031 |
USD 5.42 Billion |
|
Growth Rate CAGR |
CAGR of 6.5% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Techniques, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Smith & Nephew Plc, Olympus Corporation, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Ethicon, LLC. (Johnson & Johnson), Medtronic Plc, Hologic Corporation, Minerva Surgical, Inc., The Cooper Companies, Inc. (Cooper Surgical Inc.), AngioDynamics Inc. and other prominent players |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
